ArticleAfrican health sciences2026
Impact of metabolic syndrome on the progression of arterial stiffness in people of African ancestry.
Article in African health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MS) is an atherogenic risk factor influenced by both modifiable and non-modifiable risk factors, including race, hypertension, obesity, and age. This study evaluated the association between MS and arterial stiffness (AS) in individuals of African ancestry. Methods: Using WHO criteria, MS was assessed in 668 participants aged 18-70 years. Obesity was evaluated through body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR). Blood pressure (BP) measurements included office BP, 24-hour ambulatory BP monitoring (ABPM), and daytime/nighttime BP. Arterial stiffness was assessed via pulse wave velocity (PWV). Blood samples were analyzed for triglycerides (TG), high-density lipoprotein (HDL), and fasting blood glucose. Statistical analysis was performed using SPSS and STATA. Results: The prevalence of metabolic syndrome increased with age and was significantly higher in females. Participants with MS had a higher prevalence of hypertension and obesity. PWV was significantly associated with BP parameters and obesity indices (BMI, WC, WHR). Moreover, PWV was higher in individuals with MS compared to those without. Conclusion: Obesity and hypertension, key diagnostic components of MS, are independently associated with arterial stiffness. This underscores their role in driving target organ damage among individuals with MS in this African ancestry cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.